News Focus
News Focus
Followers 240
Posts 15530
Boards Moderated 1
Alias Born 03/29/2014

Re: MI Dendream post# 416933

Friday, 11/12/2021 12:12:33 PM

Friday, November 12, 2021 12:12:33 PM

Post# of 828368
It took me a freaking hour to find this statement in the filings. This is the 3rd time I've gone hunting for it, lol.

The passage does not state that the company has applied for a BLA, but it implies that (at that time, anyway) the company was looking to move forward with those regulatory applications, and to use the SAB and other consultants to do so.

This report was filed August 10, 2020, two months before data lock.

From their 2nd Quarter 2020 Q:

Item 5. Other Information

Consulting Agreements

The Company is in the process of entering into expanded agreements with certain Scientific Advisory Board members and certain other key consultants whom the Company anticipates will play important roles in helping the Company prepare for potential applications for regulatory approvals of the DCVax-L product. The agreements are being negotiated around structures that are contingent upon major milestones and will provide substantial incentive compensation.



https://www.sec.gov/ix?doc=/Archives/edgar/data/1072379/000110465920092797/nwbo-20200630x10q.htm#Item5OtherInformation_429861

There has been no reference to this passage in following Qs.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News